We are live on ! Find out more
CCS

Crosspoint Capital Strategies Portfolio holdings

AUM $50.4M
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+20.36%
1 Year Est. Return
-15.37%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$300M
AUM Growth
Cap. Flow
+$255M
Cap. Flow %
85.02%
Top 10 Hldgs %
21.15%
Holding
578
New
578
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 25.17%
2 Healthcare 18.72%
3 Communication Services 13.88%
4 Industrials 11.7%
5 Energy 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CADX
426
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$11K ﹤0.01%
+782
New +$5.65K
AEE icon
427
Ameren
AEE
$29.6B
$10K ﹤0.01%
+250
New +$8.97K
ARWR icon
428
Arrowhead Research
ARWR
$12.5B
$10K ﹤0.01%
+491
New +$3.93K
BNY
429
Bank of New York Mellon
BNY
$110B
$10K ﹤0.01%
+300
New +$9.77K
IAI icon
430
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.42B
$10K ﹤0.01%
+250
New +$8.93K
IXP icon
431
iShares Global Comm Services ETF
IXP
$500M
$10K ﹤0.01%
+147
New +$9.89K
NVO
432
Novo Nordisk
NVO
$205B
$10K ﹤0.01%
+2,100
New +$36.6K
RIG icon
433
Transocean
RIG
$6.41B
$10K ﹤0.01%
+238
New +$11.6K
SMCI icon
434
Super Micro Computer
SMCI
$24.9B
$10K ﹤0.01%
+4,930
New +$7.45K
LUMO
435
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$10K ﹤0.01%
+29
New +$5.16K
WBMD
436
DELISTED
WebMD Health Corp.
WBMD
$10K ﹤0.01%
+221
New +$7.97K
GEVA
437
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$10K ﹤0.01%
+100
New +$5.93K
BRW
438
Saba Capital Income & Opportunities Fund
BRW
$329M
$9K ﹤0.01%
+737
New +$8.78K
EQNR icon
439
Equinor
EQNR
$98.6B
$9K ﹤0.01%
+351
New +$8.1K
MFIC icon
440
MidCap Financial Investment
MFIC
$799M
$9K ﹤0.01%
+333
New +$8.56K
PSX icon
441
Phillips 66
PSX
$95.7B
$9K ﹤0.01%
+121
New +$8.07K
BRCM
442
DELISTED
BROADCOM CORP CL-A
BRCM
$9K ﹤0.01%
+300
New +$8.17K
WBK
443
DELISTED
Westpac Banking Corporation
WBK
$9K ﹤0.01%
+300
New +$9.17K
LNKD
444
DELISTED
LinkedIn Corporation
LNKD
$9K ﹤0.01%
+42
New +$9.56K
AMT icon
445
American Tower
AMT
$81.2B
$8K ﹤0.01%
+100
New +$7.76K
ED icon
446
Consolidated Edison
ED
$39.5B
$8K ﹤0.01%
+144
New +$8.1K
FXI icon
447
iShares China Large-Cap ETF
FXI
$4.2B
$8K ﹤0.01%
+216
New +$8.25K
NUE icon
448
Nucor
NUE
$57.3B
$8K ﹤0.01%
+150
New +$7.74K
PARA
449
DELISTED
Paramount Global Class B
PARA
$8K ﹤0.01%
+126
New +$7.41K
PCH
450
DELISTED
PotlatchDeltic
PCH
$8K ﹤0.01%
+208
New +$8.43K

Similar funds

Crosspoint Capital Strategies's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Crosspoint Capital Strategies, which disclosed 578 positions worth $300M. Its ten largest holdings account for 21% of the portfolio.

Its largest position is Manhattan Associates: 670,708 shares worth $6.53M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, followed by Healthcare and Communication Services.

  • Crosspoint Capital Strategies's largest Q4 2013 buy was Manhattan Associates: 670,708 shares worth $6.53M.
  • Crosspoint Capital Strategies's ten largest holdings make up 21% of its $300M portfolio in Q4 2013.
  • Crosspoint Capital Strategies disclosed 578 positions in Q4 2013, its first 13F filing on record.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2013, filed 6 Mar 2014.